Eli Lilly and Company

Associate Director - SAP Inventory Management Architect

Chester, Maryland, United States

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, Information TechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Technology, or a related technical field, and a minimum of 10 years of professional experience implementing and maintaining SAP systems. Experience supporting pharmaceutical manufacturing and a strong understanding of quality processes in IT applicable to procurement and distribution are also required. Familiarity with business processes in the procurement, receiving, warehousing, and distribution/delivery space is essential.

Responsibilities

As an Associate Director - SAP Inventory Management Architect, the candidate will focus on the design and implementation of SAP Inventory Management solutions to ensure efficient processes and integrations with logistical service providers. They will partner with business SMEs, cross-functional solution architects, and third-party service providers to influence strategy and design decisions, mentor IT colleagues, and communicate complex technical information to stakeholders. The role involves establishing key relationships with business users and ensuring adherence to quality, compliance, and data integrity requirements, ultimately contributing to the transformation of Lilly’s transportation management processes.

Skills

SAP Inventory Management
Transportation Management System (TMS)
Logistics Integration
Solution Architecture
Business Process Optimization
SAP Configuration
Third-party Service Integration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI